Tradestie Institutional Equity Comparison Engine

KMTS vs EKSO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EKSO Overall Edge

EKSO Captures Institutional Edge (2โ€“0 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ekso Bionics Holdings, Inc. Common Stock (EKSO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, KMTS trades at N/M Forward P/E with -134.5% operating margin (+59.9% YoY revenue) versus EKSO at N/M Forward P/E and -119.7% operating margin (-38.3% YoY). In options structure, KMTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
KMTS N/M vs EKSO N/M Fwd P/E
Growth & Margin Winner EKSO
Op Margin -134.5% vs -119.7% ยท YoY +59.9% vs -38.3%
Momentum & Technical Winner EKSO
1Y -2.8% vs +62.6% ยท 52W Pos 53% vs 87%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KMTS NASDAQ
Kestra Medical Technologies, Ltd. Common Stock
Surgical & Medical Instruments & Apparatus
$25.10
-5.75% 1D
Market Cap $1.6B
1M Return -11.37%
1Y Return -2.83%
Forward P/E N/M
Unified AI Score
46.9 / 100 HOLD
Tech 37.0 Fund 43.0 Flow 50.0 Mom 60.0
EKSO NASDAQ
Ekso Bionics Holdings, Inc. Common Stock
General Industrial Machinery & Equipment, Nec
$11.80
+0.08% 1D
Market Cap $42.0M
1M Return +25.53%
1Y Return +62.6%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KMTS -2.83% EKSO +62.6% Spread: +213.24 pp (EKSO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KMTS TTM Op. Margin: -134.5% EKSO TTM Op. Margin: -119.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KMTS vs EKSO. Trailing 12-month operating profitability (KMTS -134.5% vs EKSO -119.7%) and valuation multiples (KMTS N/M vs EKSO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KMTS (4) vs EKSO (4)
Institutional Metric KMTS EKSO Criterion Row Winner
Market Capitalization Scale $1.6B $42.0M Larger Scale KMTS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +59.9% -38.3% Higher Growth KMTS
Operating Margin (TTM) Profitability -134.5% -119.7% Higher Margin EKSO
Net Profit Margin Profitability -140.4% -91.4% Higher Margin EKSO
Return on Equity (ROE) Capital Efficiency -73.7% -107.6% Higher ROE KMTS
52-Week Range Position Momentum 53% ($17โ€“$32) 87% ($0โ€“$14) Stronger Trend EKSO
Beta / 30D Volatility Risk Regime 1.74ฮฒ ยท 63% Vol 2.16ฮฒ ยท 76% Vol Lower Realized Risk KMTS
Unified Institutional Score Composite Signal 46.9 / 100 (HOLD) 58.1 / 100 (HOLD) Higher Composite EKSO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KMTS vs EKSO Buy Guide
KMTS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KMTS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EKSO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EKSO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KMTS nor EKSO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.